LYFIX vs. FPHAX
Compare and contrast key facts about AlphaCentric LifeSci Healthcare Fund (LYFIX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
LYFIX is managed by AlphaCentric Funds. It was launched on Nov 28, 2019. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Performance
LYFIX vs. FPHAX - Performance Comparison
Loading graphics...
LYFIX vs. FPHAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | -4.21% | 28.22% | -0.27% | 7.19% | -0.92% | -3.42% | 54.83% | 1.20% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.39% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 7.17% |
Returns By Period
In the year-to-date period, LYFIX achieves a -4.21% return, which is significantly lower than FPHAX's 0.39% return.
LYFIX
- 1D
- 0.93%
- 1M
- -7.36%
- YTD
- -4.21%
- 6M
- 13.80%
- 1Y
- 19.23%
- 3Y*
- 7.08%
- 5Y*
- 4.29%
- 10Y*
- —
FPHAX
- 1D
- 3.02%
- 1M
- -5.31%
- YTD
- 0.39%
- 6M
- 13.18%
- 1Y
- 34.09%
- 3Y*
- 17.36%
- 5Y*
- 12.54%
- 10Y*
- 11.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LYFIX vs. FPHAX - Expense Ratio Comparison
LYFIX has a 1.40% expense ratio, which is higher than FPHAX's 0.75% expense ratio.
Return for Risk
LYFIX vs. FPHAX — Risk / Return Rank
LYFIX
FPHAX
LYFIX vs. FPHAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AlphaCentric LifeSci Healthcare Fund (LYFIX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LYFIX | FPHAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.03 | 1.33 | -0.30 |
Sortino ratioReturn per unit of downside risk | 1.50 | 1.84 | -0.34 |
Omega ratioGain probability vs. loss probability | 1.18 | 1.24 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 1.85 | 2.50 | -0.65 |
Martin ratioReturn relative to average drawdown | 4.50 | 7.03 | -2.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LYFIX | FPHAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.03 | 1.33 | -0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 0.71 | -0.52 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.64 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.53 | -0.04 |
Correlation
The correlation between LYFIX and FPHAX is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
LYFIX vs. FPHAX - Dividend Comparison
LYFIX's dividend yield for the trailing twelve months is around 1.86%, less than FPHAX's 5.66% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LYFIX AlphaCentric LifeSci Healthcare Fund | 1.86% | 1.78% | 2.24% | 2.63% | 4.43% | 12.88% | 2.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.66% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Drawdowns
LYFIX vs. FPHAX - Drawdown Comparison
The maximum LYFIX drawdown since its inception was -35.33%, smaller than the maximum FPHAX drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for LYFIX and FPHAX.
Loading graphics...
Drawdown Indicators
| LYFIX | FPHAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.33% | -38.26% | +2.93% |
Max Drawdown (1Y)Largest decline over 1 year | -9.47% | -11.00% | +1.53% |
Max Drawdown (5Y)Largest decline over 5 years | -32.45% | -28.82% | -3.63% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.82% | — |
Current DrawdownCurrent decline from peak | -7.64% | -7.10% | -0.54% |
Average DrawdownAverage peak-to-trough decline | -10.07% | -9.21% | -0.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.23% | 4.30% | -0.07% |
Volatility
LYFIX vs. FPHAX - Volatility Comparison
AlphaCentric LifeSci Healthcare Fund (LYFIX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX) have volatilities of 6.67% and 6.89%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LYFIX | FPHAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.67% | 6.89% | -0.22% |
Volatility (6M)Calculated over the trailing 6-month period | 13.17% | 14.30% | -1.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.01% | 23.52% | -4.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 17.74% | +5.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.45% | 17.81% | +5.64% |